← Browse by Condition
Medical Condition
hemophilia a
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 4, Phase 3
NCT06684314
Recruiting
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan
Enrollment
100 pts
Location
Taiwan
Sponsor
Sanofi
NCT06816056
Recruiting
Manual Therapy in Hemophilic Arthropathy of the Ankle
Enrollment
13 pts
Location
Spain
Sponsor
Investigación en Hemofilia y F...
NCT06940830 Phase 4
Recruiting
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Enrollment
250 pts
Location
Croatia, Czechia, Fr...
Sponsor
Swedish Orphan Biovitrum
NCT05145127 Phase 3
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Enrollment
245 pts
Location
United States, Austr...
Sponsor
Pfizer
NCT06147414
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Enrollment
550 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT07314983
Recruiting
Long-term Anticoagulation in a Patient With Severe Hemophilia A
Enrollment
1 pts
Location
France
Sponsor
University Hospital, Strasbour...
NCT04728841
Recruiting
Gene Therapy for Chinese Hemophilia A
Enrollment
12 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT04563520 Phase 3
Recruiting
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Enrollment
5 pts
Location
United States
Sponsor
Emory University